Kaya Holdings (KAYS) Liabilities and Shareholders Equity (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Liabilities and Shareholders Equity of $199358.0 in Q3 2025, down 21.65% quarter-over-quarter from $254430.0 in Q2 2025, and down 25.78% on a YoY basis from $268589.0 in Q3 2024.
Kaya Holdings (KAYS) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends
Kaya Holdings' Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $199358.0 for Q3 2025.
- In Q3 2025, Liabilities and Shareholders Equity fell 25.78% year-over-year to $199358.0; the TTM figure through Sep 2025 stood at $867446.0 (down 14.35% YoY), while the FY2024 annual figure was $216369.0, changed 0.24% from the prior year.
- Liabilities and Shareholders Equity was $199358.0 for Q3 2025 at Kaya Holdings, down from $254430.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 million in Q1 2021 to a low of $197289.0 in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $788176.8 across 5 years, with a median of $300680.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity tumbled 76.02% in 2023, then gained 17.13% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.6 million in 2021, then tumbled by 46.26% to $843241.0 in 2022, then sank by 74.4% to $215856.0 in 2023, then increased by 0.24% to $216369.0 in 2024, then slipped by 7.86% to $199358.0 in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $199358.0 (Q3 2025), $254430.0 (Q2 2025), and $197289.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Kaya Holdings | - | - | 5,370.00 | 199,358.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 199,358.00 |
| Jun 30, 2025 | 254,430.00 |
| Mar 31, 2025 | 197,289.00 |
| Dec 31, 2024 | 216,369.00 |
| Sep 30, 2024 | 268,589.00 |
| Jun 30, 2024 | 300,680.00 |
| Mar 31, 2024 | 227,614.00 |
| Dec 31, 2023 | 215,856.00 |
| Sep 30, 2023 | 230,550.00 |
| Jun 30, 2023 | 256,709.00 |
| Mar 31, 2023 | 304,879.00 |
| Dec 31, 2022 | 843,241.00 |
| Sep 30, 2022 | 961,522.00 |
| Jun 30, 2022 | 987,515.00 |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | 2.20 Mn |
| Jun 30, 2021 | 2.27 Mn |
| Mar 31, 2021 | 2.30 Mn |
| Dec 31, 2020 | 2.30 Mn |